Supply Chain Intelligence about:

Cipla Ltd.

Company profile

India

See Cipla Ltd.'s products and customers

Thousands of companies like you use Panjiva to research suppliers and competitors.

Sign Up

Easy access to trade data

Explore trading relationships hidden in supply chain data

Contact information for Cipla Ltd.

Address

CIPLA HOUSE, PENINSULA BUSINESS PARK GANPATRAO KADAM MARG LOWER PAREL MUMBAI, MAHARASHTRA 400 013

See more goods shipped on Panjiva

Recent Panjiva Research about Cipla Ltd.

Cipla scales up imports as Moderna gets Indian vaccine nod

June 30, 2021

The Indian government has approved imports of Moderna’s SARS-COV-2 vaccine, to be handled by Cipla, as it seeks to tackle the pandemic via both imports and retention of domestically produced vaccines. Cipla’s supply chain activity has already been increasing with Indian imports linked to the f... Read more →

4Q 2019 Outlook: A Range of Convenient Enemies – U.S. Trade Policy

October 1, 2019

U.S. trade policy is likely to become more rather than less complicated during the fourth quarter, with seven major issues to watch. The passage of the U.S.-Mexico-Canada Agreement may be accelerated as a result of the impeachment process, but in the meantime the U.S. trade deficit with Mexico... Read more →

Are Pharma Imports Reddy for Trump?

January 11, 2017

The latest industry to face President-elect Trump’s attention is pharmaceutical manufacturing, where a commitment has been made to cut costs. While it is not clear how this will be achieved, the U.S. has made significant use of imported generic drugs once branded versions’ patents end. Panjiva... Read more →

Pre-Holiday Heartburn Drug Imports Led by Teva and Cipla

December 28, 2016

U.S. imports of P-PI drugs to manage gastrointestinal disorders climbed 30% in November to reach an all time high, Panjiva data shows. This reflects increased imports of esomeprazole, the generic version of AstraZeneca’s Nexium, which jumped 743% in the past three months on a year earlier. Tha... Read more →

Lamotrigine Leads AC Drug Import Growth, GSK Doesn’t Gain

November 21, 2016

U.S. imports of anticonvulsant drugs (AC), used for epilepsy, migraine and bipolar treatments, climbed 42% in October, the 18th straight increase. This was led by lamotrigine which jumped 150%. Generic drugmakers including Aurobindo Pharma, Cipla and Cadila have taken the lion’s share of the g... Read more →

Thousands of companies use Panjiva to research suppliers and competitors